Recursion Pharmaceuticals Statistics

Total Valuation

RXRX has a market cap or net worth of $1.87 billion. The enterprise value is $1.29 billion.

Market Cap	1.87B
Enterprise Value	1.29B

Important Dates

The next estimated earnings date is Tuesday, August 4, 2026, before market open.

Earnings Date	Aug 4, 2026
Ex-Dividend Date	n/a

Share Statistics

RXRX has 530.76 million shares outstanding. The number of shares has increased by 51.66% in one year.

Current Share Class	524.68M
Shares Outstanding	530.76M
Shares Change (YoY)	+51.66%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	3.01%
Owned by Institutions (%)	67.11%
Float	513.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.13
Forward PS	24.30
PB Ratio	1.82
P/TBV Ratio	3.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	19.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.47, with a Debt / Equity ratio of 0.07.

Current Ratio	5.47
Quick Ratio	5.15
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-354.28

Financial Efficiency

Return on equity (ROE) is -57.16% and return on invested capital (ROIC) is -34.44%.

Return on Equity (ROE)	-57.16%
Return on Assets (ROA)	-27.66%
Return on Invested Capital (ROIC)	-34.44%
Return on Capital Employed (ROCE)	-48.38%
Weighted Average Cost of Capital (WACC)	9.48%
Revenue Per Employee	$110,680
Profits Per Employee	-$932,960
Employee Count	600
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	-4.58M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.78% in the last 52 weeks. The beta is 1.00, so RXRX's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-31.78%
50-Day Moving Average	3.32
200-Day Moving Average	4.12
Relative Strength Index (RSI)	57.88
Average Volume (20 Days)	21,802,734

Short Selling Information

The latest short interest is 184.02 million, so 34.67% of the outstanding shares have been sold short.

Short Interest	184.02M
Short Previous Month	164.34M
Short % of Shares Out	34.67%
Short % of Float	35.81%
Short Ratio (days to cover)	9.90

Income Statement

In the last 12 months, RXRX had revenue of $66.41 million and -$559.78 million in losses. Loss per share was -$1.17.

Revenue	66.41M
Gross Profit	-428.74M
Operating Income	-585.27M
Pretax Income	-564.36M
Net Income	-559.78M
EBITDA	-501.23M
EBIT	-585.27M
Loss Per Share	-$1.17

Full Income Statement

Balance Sheet

The company has $654.47 million in cash and $72.38 million in debt, giving a net cash position of $582.10 million or $1.10 per share.

Cash & Cash Equivalents	654.47M
Total Debt	72.38M
Net Cash	582.10M
Net Cash Per Share	$1.10
Equity (Book Value)	1.02B
Book Value Per Share	1.93
Working Capital	579.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$320.95 million and capital expenditures -$4.90 million, giving a free cash flow of -$325.85 million.

Operating Cash Flow	-320.95M
Capital Expenditures	-4.90M
Depreciation & Amortization	84.04M
Net Borrowing	-8.59M
Free Cash Flow	-325.85M
FCF Per Share	-$0.61

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-881.32%
Pretax Margin	-849.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RXRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.66%
Shareholder Yield	n/a
Earnings Yield	-29.96%
FCF Yield	-17.44%

Analyst Forecast

The average price target for RXRX is $6.64, which is 88.64% higher than the current price. The consensus rating is "Hold".

Price Target	$6.64
Price Target Difference	88.64%
Analyst Consensus	Hold
Analyst Count	8
Revenue Growth Forecast (3Y)	27.20%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RXRX has an Altman Z-Score of 0.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.98
Piotroski F-Score	3